NEW YORK (Reuters) - Pfizer Inc. on Monday said the Federal Court of Appeal of Canada has blocked generic drugmaker Teva Pharmaceutical Industries Ltd. from launching a copycat form of its Celebrex arthritis drug in the country until 2014.

[News Source]